SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor

This publication has 9 references indexed in Scilit:

• The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
  Bioorganic & Medicinal Chemistry Letters, 1999
• Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
  Clinical Pharmacology & Therapeutics, 1999
• Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats
  Inflammation Research, 1998
• Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors, using sensitive microsomal and platelet assays
  Canadian Journal of Physiology and Pharmacology, 1997
• Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor
  British Journal of Pharmacology, 1997
• Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)
  Journal of Medicinal Chemistry, 1997
• Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives
  Journal of Medicinal Chemistry, 1995
• Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy
  Biomedical Research, 1994
• Cloning and Expression of Rat Prostaglandin Endoperoxide Synthase (Cyclooxygenase)-2 cDNA
  Biochemical and Biophysical Research Communications, 1993